Statistics about Health, Pharma & Medtech in United States
Statistics
- Nanoviricides net cash 2021-2025
- Nanoviricides net income 2021-2025
- Natural Alternatives total equity 2021-2025
- Natural Alternatives net cash 2021-2025
- Natural Alternatives operating profit 2021-2025
- Natural Alternatives gross profit 2021-2025
- Natural Alternatives revenue 2021-2025
- Neogen net cash 2020-2024
- Neogen operating profit 2020-2024
- Neogen gross profit 2020-2024
- Neogen revenue 2020-2024
- Neogen net income 2020-2024
- Kaya Holdings total equity 2020-2024
- Kaya Holdings revenue 2020-2024
- Kaya Holdings operating profit 2020-2024
- Kalvista Pharmaceuticals net cash 2020-2024
- Kalvista Pharmaceuticals net income 2020-2024
- Kalvista Pharmaceuticals operating profit 2020-2024
- Integrated Biopharma Inc total equity 2021-2025
- Integrated Biopharma Inc net cash 2021-2025
- Integrated Biopharma Inc gross profit 2021-2025
- Igc Pharma, Inc. net cash 2020-2024
- Igc Pharma, Inc. operating profit 2020-2024
- Igc Pharma, Inc. revenue 2020-2024
- Igc Pharma, Inc. gross profit 2020-2024
- Igc Pharma, Inc. net income 2020-2024
- Earth Science Tech total equity 2020-2024
- Earth Science Tech net cash 2020-2024
- Earth Science Tech gross profit 2020-2024
- Earth Science Tech revenue 2020-2024
- Cytodyn total equity 2021-2025
- Cytodyn net cash 2020-2024
- Cytodyn operating profit 2020-2024
- Cyanotech Corp total equity 2020-2024
- Cyanotech Corp net cash 2020-2024
- Cyanotech Corp gross profit 2020-2024
- Cyanotech Corp operating profit 2020-2024
- Cyanotech Corp revenue 2020-2024
- Cnbx Pharmaceuticals total equity 2021-2025
- Cnbx Pharmaceuticals operating profit 2021-2025
- Champions Oncology total equity 2020-2024
- Champions Oncology net cash 2020-2024
- Champions Oncology revenue 2020-2024
- Burzynski Research Institute total equity 2020-2024
- Burzynski Research Institute operating profit 2020-2024
- Burzynski Research Institute net cash 2020-2024
- Burzynski Research Institute net income 2022-2024
- Biomerica total equity 2021-2025
- Biomerica net cash 2020-2024
- Biomerica revenue 2020-2024
- Biomerica operating profit 2020-2024
- Biomerica gross profit 2020-2024
- Biovie total equity 2021-2025
- Biovie operating profit 2021-2025
- Biovie net cash 2021-2025
- Biovie net income 2021-2025
- Aytu Bioscience total equity 2021-2025
- Aytu Bioscience net cash 2021-2025
- Aytu Bioscience revenue 2021-2025
- Aytu Bioscience gross profit 2021-2025
- Aytu Bioscience operating profit 2021-2025
- Arrowhead Pharmaceuticals, Inc. net income 2021-2025
- Arrowhead Pharmaceuticals, Inc. operating profit 2021-2025
- Arrowhead Pharmaceuticals, Inc. revenue 2021-2025
- Arrowhead Pharmaceuticals, Inc. net cash 2021-2025
- Anebulo Pharmaceuticals net cash 2021-2025
- Anebulo Pharmaceuticals total equity 2021-2025
- Prevalence of health conditions in the U.S. 2025
- Dogwood Therapeutics, Inc. total equity 2020-2024
- Dogwood Therapeutics, Inc. net cash 2020-2024
- Dogwood Therapeutics, Inc. net income 2020-2024
- Dogwood Therapeutics, Inc. operating profit 2020-2024
- Dogwood Therapeutics, Inc. liabilities 2020-2024
- Sunshine Biopharma Inc. net income 2017-2021
- PALVELLA THERAPEUTICS, INC. revenue 2019-2023
- AIBOTICS, INC. total equity 2020-2024
- AIBOTICS, INC. net cash 2020-2024
- AIBOTICS, INC. operating profit 2020-2024
- AIBOTICS, INC. net income 2018-2020
- Ernexa Therapeutics Inc. revenue 2019-2024
- Ernexa Therapeutics Inc. net income 2010-2012
- Tvardi Therapeutics, Inc. revenue 2020-2024
- Export value of pharmaceutical products from Singapore to the U.S. 2015-2024
- Usage of Cannabis products in the U.S. 2024
- Zynerba Pharmaceuticals, Inc. total equity 2018-2022
- Zosano Pharma Corp total equity 2017-2021
- Zynerba Pharmaceuticals, Inc. net cash 2018-2022
- Zosano Pharma Corp net cash 2018-2021
- Zynerba Pharmaceuticals, Inc. liabilities 2018-2022
- Zosano Pharma Corp liabilities 2017-2021
- Zynerba Pharmaceuticals, Inc. operating profit 2018-2022
- Zosano Pharma Corp operating profit 2017-2021
- Zynerba Pharmaceuticals, Inc. revenue 2016-2018
- Zosano Pharma Corp revenue 2017-2021
- Zynerba Pharmaceuticals, Inc. net income 2018-2022
- Xenetic Biosciences, Inc. gross profit 2012-2014
- Xenetic Biosciences, Inc. net income 2012-2021
- Ibio, Inc. gross profit 2020-2022
- Effector Therapeutics, Inc. total equity 2019-2023
- Effector Therapeutics, Inc. net cash 2020-2023